Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression

Hongchun Wei, Bing Li, Kok Pin Ng, Qingxi Fu, Shengjie Dong, Maowen Ba, Min KongChinese 2021 · DOI

Abstract

In future clinical trials, specific CSF and cognitive measures that predict dementia progression in A+T+MCI might be useful risk factors for assessing the risk of dementia progression.
BibTeX
@inproceedings{wei2021amyloid,
  author = {Hongchun Wei and Bing Li and Kok Pin Ng and Qingxi Fu and Shengjie Dong and Maowen Ba and Min Kong},
  title = {{Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression}},
  booktitle = {Chinese},
  year = {2021},
  doi = {10.1097/cm9.0000000000001496},
}

Loading related content...

Figure